Fate Therapeutics (FATE) Stock Highlights

1.68 | +1.2%

2024-12-21 06:01:50

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The companys cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Statistics

Range Today

1.64 1.8

Volume Today 10.13M

Range 1 Year

1.59 8.83

Volume 1 Year 606.25M

Range 3 Year

1.59 66.56

Volume 3 Year 1.64B

Range 10 Year

1.46 121.16

Volume 10 Year 2.69B

Highlights

Market Capitalization 290.99M (small)

Floating Shares 98.77M

Current Price 1.68

Price To Earnings -1.57

Price To Revenue 5.79

Price To Book 0.69

Earnings Per Share -1.61

Payout Ratio 0%

Performance

Latest +1.2%

1 Month -22.22%

3 Months -57.47%

6 Months -50.73%

1 Year -48.31%

3 Years -97.12%

5 Years -91.53%

10 Years -68.12%

Benchmarks

Market Capitalization

145 / 368

Gross Profits

264 / 278

Total Revenue

87 / 300

Total Rank

124 / 368

Free Cashflow

293 / 352

Performance 5 years

278 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.